by John Conrad | Nov 20, 2025 | Member News
Abbott confirmed a $21 billion deal to acquire Exact Sciences, instantly becoming one of the biggest moves in diagnostics in years. Abbott will pay $105 per share in cash, a 51% premium, sending Exact’s stock sharply higher for a second straight day. The deal gives...
by Randy | Apr 4, 2019 | Featured, iBIO News
Meeting the Future Needs of a Changing Community iBIO is excited to release our 2019 State of the Industry Report, titled Meeting the Future Needs of a Changing Community. This report provides an overview of the life sciences innovation community, benchmarks our...
